Nukkleus Inc. Files Routine 8-K on Jan 26, No Major Changes

Ticker: DFNSW · Form: 8-K · Filed: Jan 26, 2024 · CIK: 1787518

Complexity: simple

Sentiment: neutral

Topics: corporate-governance, routine-filing

TL;DR

**Nukkleus Inc. filed a standard 8-K, nothing major to see here.**

AI Summary

Nukkleus Inc. filed an 8-K on January 26, 2024, reporting an event that occurred on January 19, 2024. This filing is a standard current report, indicating no major changes in leadership, financial statements, or exhibits, but rather a routine disclosure. For investors, this suggests a period of stability for Nukkleus Inc., as there are no immediate red flags or significant corporate actions that would drastically alter the company's trajectory or valuation based on this specific filing.

Why It Matters

This routine 8-K filing indicates business as usual for Nukkleus Inc., providing no new information that would significantly impact investment decisions. It suggests a stable operational period without immediate major corporate events.

Risk Assessment

Risk Level: low — The filing is a routine 8-K with no significant disclosures of events that would introduce new risks or changes to the company's operations or financial health.

Analyst Insight

Investors should note this is a routine filing with no new material information, suggesting no immediate action is required based solely on this document. Continue to monitor future filings for substantive updates.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by Nukkleus Inc.?

This 8-K filing is a 'Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934,' indicating a routine disclosure of an event that occurred on January 19, 2024, and was filed on January 26, 2024.

What specific items are reported in this 8-K filing?

The filing lists 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers,' 'Regulation FD Disclosure,' and 'Financial Statements and Exhibits' under Item Information, but the content of the filing itself does not detail any specific changes or events under these items, suggesting a placeholder or no material changes.

When was the earliest event reported in this 8-K?

The earliest event reported in this 8-K occurred on January 19, 2024, as stated in the 'Date of Report (Date of earliest event reported)' section.

What was the former name of Nukkleus Inc.?

The former name of Nukkleus Inc. was Brilliant Acquisition Corporation, as indicated in the 'Former name or former address, if changed since last report' section of the filing.

What is Nukkleus Inc.'s business address and phone number?

Nukkleus Inc.'s business address is 525 Washington Blvd, Jersey City, New Jersey, 07310, and its telephone number is 212-791-4663, according to the filing.

Filing Stats: 744 words · 3 min read · ~2 pages · Grade level 11.4 · Accepted 2024-01-26 17:15:36

Key Financial Figures

Filing Documents

02. Departure of Directors or Certain Officers; Election

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 19, 2024, the Board of Directors (the "Board") of Nukkleus Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, expanded the Board from six members to seven members and appointed Colonel Derek Campbell to the Board, effective immediately. Mr. Campbell will hold office until the next annual meeting of the shareholders and until his successor has been elected or until his earlier resignation or removal. Mr. Campbell's background spans the energy, natural resources, infrastructure, security, and defense sectors. He currently serves as the Group Managing Partner of LVC Global Holdings, LLC, an international asset acquisition, investment, and consulting platform with a focus on Emerging and Frontier Markets, particularly Africa. As an accomplished business leader and a Colonel in the United States Marine Corps Reserves, Campbell previously held high-level positions in the U.S. military, including key roles in African countries such as Nigeria and South Sudan. Mr. Campbell will participate in the Company's standard compensation arrangements for non-employee directors, as more particularly described in the proxy statement/prospectus filed with the Securities and Exchange Commission on November 14, 2023. There is no arrangement or understanding between Mr. Campbell and any other person pursuant to which Mr. Campbell was elected as a director of the Company.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 26, 2024, the Company issued a press release announcing the appointment of Mr. Campbell to the Board of the Company. A copy of the press release filed with this Current Report on Form 8-K as Exhibit 99.1. The information in the press release attached as Exhibit 99.1 hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01. Exhibits

Item 9.01. Exhibits The exhibits filed or furnished with this report are listed in the following Exhibit Index: Exhibit No. Description 99.1 Press Release dated January 26, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Nukkleus Inc. (Registrant) Dated: January 26, 2024 By: /s/ Emil Assentato Name: Emil Assentato Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing